Compound Creams in Personal Injury Cases: What Attorneys and Patients Should Know

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | May 7, 2024 | 7 min read

Compound creams are customized topical pain medications frequently prescribed in personal injury cases for localized musculoskeletal and neuropathic pain. Here's what PI attorneys and patients need to understand about their clinical role and documentation in lien-based cases.

Compound Creams in Personal Injury Cases

Compound creams — also called compounded topical preparations or compounded analgesic creams — are among the most commonly prescribed medications in personal injury cases involving soft tissue injuries, musculoskeletal pain, and neuropathic symptoms. Unlike commercially manufactured drugs, compound creams are formulated by a licensed compounding pharmacist specifically for an individual patient, combining active pharmaceutical ingredients in concentrations and combinations not available in standard commercial products.

For PI attorneys managing lien-based pharmacy access, compound creams occupy a specific and important role: they are clinically valuable, frequently prescribed, and require proper documentation to support the lien at settlement.

[!KEY] Compound creams combine multiple active agents in a single topical preparation — addressing inflammation, nerve pain, and muscle spasm simultaneously — and are covered under pharmacy lien with clinical documentation that defends the formulation at settlement.

What Is a Compound Cream?

A compound cream is a topical preparation that combines one or more active pharmaceutical ingredients in a cream, gel, or ointment base. The compounding pharmacist formulates the preparation to the prescribing physician's specifications — choosing specific drugs, concentrations, and delivery vehicles based on the individual patient's clinical presentation.

In personal injury cases, common active ingredients in compounded topical preparations include:

• Diclofenac: an NSAID anti-inflammatory for joint and soft tissue inflammation
• Ketoprofen: another NSAID used for musculoskeletal pain
• Gabapentin: in topical form, used for peripheral neuropathic pain
• Cyclobenzaprine: for localized muscle spasm
• Lidocaine: for localized anesthetic effect
• Baclofen: for focal spasticity
• Ketamine: at low concentrations, for complex regional pain syndrome and refractory neuropathic pain
• Amitriptyline: a tricyclic antidepressant with demonstrated topical analgesic properties

A single compound cream may contain two or more of these agents simultaneously — for example, a diclofenac/gabapentin/cyclobenzaprine cream targeting a patient with combined inflammatory, neuropathic, and spasm symptoms.

Why Compound Creams Are Prescribed in PI Cases

Targeting Localized Pain

Personal injury cases frequently involve injuries that are anatomically localized — a specific cervical level, a knee joint, a shoulder, a specific distribution of radicular pain. Topical preparations allow the treating physician to deliver therapeutic concentrations of active agents directly to the affected area, minimizing systemic exposure and the side effect burden that comes with oral medications.

A patient with chronic neck pain from a C5-C6 disc herniation may tolerate a compounded cervical cream better than an oral anti-inflammatory plus a separate oral neuropathic agent, particularly if they are elderly, have renal considerations, or are taking other medications.

[!KEY] A compound cream prescribed for an elderly PI patient with renal impairment is not a luxury prescription — the treating physician's clinical notes documenting that standard oral NSAIDs were contraindicated establish the formulation as a medical necessity, and that necessity documentation is what defeats the defense's "overpriced compounded medication" challenge at settlement.

Tolerability for High-Risk Patients

Some PI clients — elderly patients, patients with gastrointestinal sensitivities, patients with renal or hepatic impairment — cannot tolerate standard oral anti-inflammatory medications. Compounded topical preparations offer an alternative delivery route that avoids many of the systemic risks associated with oral NSAIDs, opioids, or muscle relaxants.

Complex Pain Presentations

Post-collision injuries often involve multiple pain mechanisms simultaneously: inflammation, muscle spasm, and neuropathic pain from nerve compression or irritation. A compounded preparation can address multiple mechanisms in a single application rather than requiring the patient to manage multiple separate oral medications.

Compound Creams and Pharmacy Liens

Compounded medications are not dispensed at standard retail pharmacies — they require a licensed compounding pharmacy. In a lien-based pharmacy program like LienScripts, compound creams are dispensed through the network when ordered by the treating physician and approved through the program's clinical review process.

Documentation Requirements

Because compound creams are individually formulated and can represent significant prescription value, proper documentation is essential. LienScripts' MERIT (Medication Evaluation & Rationale for Injury Treatment) report includes:

• The specific formulation dispensed for each patient
• The prescribing physician and clinical indication
• The date of each dispensing
• The clinical narrative explaining the therapeutic rationale

This documentation is critical for demand packages and lien negotiations, where opposing counsel or adjusters may challenge the medical necessity of compounded medications.

[!NOTE] Compound creams may be challenged at settlement as overpriced — the defense against that challenge is the clinical documentation: the MERIT report, the treating physician's rationale, and the connection between each ingredient and the patient's documented injuries.

Medical Necessity in Compound Prescriptions

Compound cream prescriptions in PI cases should be supported by clear clinical documentation from the treating physician — specifically articulating why a commercial alternative was not selected, what the targeted pain mechanism is, and how the compounded formulation addresses the patient's individual clinical presentation. LienScripts' clinical documentation captures this rationale to support the lien at settlement.

What Attorneys Should Know

Compound Creams Are Appropriate in the Right Cases

Compound creams are not inherently problematic or overutilized when prescribed appropriately. When a treating physician with clinical justification orders a compounded preparation for a patient with a documented injury and a clear therapeutic rationale, the prescription is appropriate and defensible at settlement.

Documentation Is the Critical Variable

Compound creams are sometimes challenged at settlement or during lien negotiation because they represent a higher per-prescription cost than standard commercial medications. The defense against such challenges is documentation — clinical notes from the treating physician, the MERIT report, and the medication's connection to the documented injury.

[!KEY] Enrolling in the pharmacy lien program before the first compound cream is dispensed — rather than after — means every fill is documented from day one in the MERIT report; attempting to add compound cream documentation retrospectively is exactly what adjusters challenge as reconstructed rather than contemporaneous clinical evidence.

Enrollment Early Ensures Full Prescription Coverage

If your client is likely to receive compound medications — particularly in cases involving cervical disc injuries, chronic soft tissue injuries, or complex regional pain syndrome — enrolling them in LienScripts at intake ensures full coverage from the first dispense.

Related Resources

• What Is a MERIT Report?
• Gabapentin for Nerve Pain After Whiplash
• Cyclobenzaprine After a Rear-End Collision
• Zero Upfront Cost Prescriptions for PI Clients
• Pharmacy Services for Personal Injury Clients: How It Works
• What Are Medication Liens?